Use
For prevention/treatment of respiratory syncytial virus (RSV)
Features
First monoclonal antibody approved by the FDA for an infectious disease.
NIH Contribution
Derivation of monoclonal antibodies directed against RSV
Success Stories
http://www.ott.nih.gov/pdfs/SynagisCS.pdf